Department of Mechanical Engineering
Inki Kim is a Ph.D candidate in Department of Mechanical Engineering, Pohang University of Science and Technology (POSTECH), Republic of Korea. He received his bachelor degree with highest honor in Ulsan National Institute of Science and Technology (UNIST), Republic of Korea.
During his Ph.D training under supervision of Prof. Junsuk Rho, he developed multifunctional flat optical devices based on metasurfaces including holographic display, flat lens and color filters. To realize active/dynamic metaphotonic devices, he developed phase-change-material integrated flat optical devices. Also he invented advanced nanofabrication techniques such as ultra-accurate electron beam lithography overlay with sub-20 nm accuracy and single-digit-nanometer scale lithography.
Inki Kim received SPIE Optics and Photonics Scholarship from International Society for Optics and Photonics (SPIE) in 2020, Carlsberg Foundation Scholarship from The 9th International Conference on Surface Plasmon Photonics in 2019, and Global Ph.D. Fellowship from Korean Government in 2016.
Chemical biology investigation of cell death pathways activated by endoplasmic reticulum stress reveals cytoprotective modulators of ASK1.
The Journal of biological chemistry Jan, 2009 | Pubmed ID: 19004820
Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities.
Nature reviews. Drug discovery Dec, 2008 | Pubmed ID: 19043451
Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer.
Science translational medicine Jan, 2011 | Pubmed ID: 21270338
Ibudilast, a phosphodiesterase inhibitor with anti-inflammatory activity, protects against ischemic brain injury in rats.
Brain research Jan, 2012 | Pubmed ID: 22137656
Downregulation of Mcl-1 by daunorubicin pretreatment reverses resistance of breast cancer cells to TNF-related apoptosis-inducing ligand.
Biochemical and biophysical research communications May, 2012 | Pubmed ID: 22554523
Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity.
European journal of medicinal chemistry Sep, 2012 | Pubmed ID: 22871485
Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity.
Bioorganic & medicinal chemistry Oct, 2012 | Pubmed ID: 22980218
Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists.
European journal of medicinal chemistry Oct, 2012 | Pubmed ID: 22982119
Carnitine sensitizes TRAIL-resistant cancer cells to TRAIL-induced apoptotic cell death through the up-regulation of Bax.
Biochemical and biophysical research communications Nov, 2012 | Pubmed ID: 23068102
Iris Nertschinskia ethanol extract differentially induces cytotoxicity in human breast cancer cells depending on AKT1/2 activity.
Asian Pacific journal of cancer prevention : APJCP , 2012 | Pubmed ID: 23464484
Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins.
Molecular and cellular biochemistry Nov, 2013 | Pubmed ID: 23846485
Down-Regulation of Survivin by Nemadipine-A Sensitizes Cancer Cells to TRAIL-Induced Apoptosis.
Biomolecules & therapeutics Jan, 2013 | Pubmed ID: 24009855
NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutants.
Investigational new drugs Jun, 2014 | Pubmed ID: 24173966
Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leukemia sequence-1 protein.
Oncology reports Jan, 2014 | Pubmed ID: 24213797
Neobavaisoflavone sensitizes apoptosis via the inhibition of metastasis in TRAIL-resistant human glioma U373MG cells.
Life sciences Jan, 2014 | Pubmed ID: 24231449
Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma.
PloS one , 2014 | Pubmed ID: 24853121
Ribosomal protein L19 overexpression activates the unfolded protein response and sensitizes MCF7 breast cancer cells to endoplasmic reticulum stress-induced cell death.
Biochemical and biophysical research communications Jul, 2014 | Pubmed ID: 24950402
CGP74514A enhances TRAIL-induced apoptosis in breast cancer cells by reducing X-linked inhibitor of apoptosis protein.
Anticancer research Jul, 2014 | Pubmed ID: 24982369
Novel peptides functionally targeting in vivo human lung cancer discovered by in vivo peptide displayed phage screening.
Amino acids Feb, 2015 | Pubmed ID: 25366491
Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Brain research Feb, 2015 | Pubmed ID: 25454795
A cisplatin‑incorporated liposome that targets the epidermal growth factor receptor enhances radiotherapeutic efficacy without nephrotoxicity.
International journal of oncology Mar, 2015 | Pubmed ID: 25544240
Depletion of the cereblon gene activates the unfolded protein response and protects cells from ER stress-induced cell death.
Biochemical and biophysical research communications Feb, 2015 | Pubmed ID: 25619137
Disparate roles of zinc in chemical hypoxia-induced neuronal death.
Frontiers in cellular neuroscience , 2015 | Pubmed ID: 25667569
Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage.
Oncotarget Apr, 2015 | Pubmed ID: 25991668
Gambogic acid induces apoptotic cell death in T98G glioma cells.
Bioorganic & medicinal chemistry letters Feb, 2016 | Pubmed ID: 26631318
Bay 61-3606 Sensitizes TRAIL-Induced Apoptosis by Downregulating Mcl-1 in Breast Cancer Cells.
PloS one , 2015 | Pubmed ID: 26720004
The small molecule '1-(4-biphenylylcarbonyl)-4-(5-bromo-2-methoxybenzyl) piperazine oxalate' and its derivatives regulate global protein synthesis by inactivating eukaryotic translation initiation factor 2-alpha.
Cell stress & chaperones May, 2016 | Pubmed ID: 26873011
In vivo and in vitro characterization of site-specific recombination of a novel serine integrase from the temperate phage EFC-1.
Biochemical and biophysical research communications Apr, 2016 | Pubmed ID: 27018384
Establishment of IL-7 Expression Reporter Human Cell Lines, and Their Feasibility for High-Throughput Screening of IL-7-Upregulating Chemicals.
PloS one , 2016 | Pubmed ID: 27589392
Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production.
Cancer letters Nov, 2016 | Pubmed ID: 27612558
Nanophotonic modal dichroism: mode-multiplexed modulators.
Optics letters Sep, 2016 | Pubmed ID: 27628406
FoxO1 in dopaminergic neurons regulates energy homeostasis and targets tyrosine hydroxylase.
Nature communications Sep, 2016 | Pubmed ID: 27681312
IK acts as an immunoregulator of inflammatory arthritis by suppressing TH17 cell differentiation and macrophage activation.
Scientific reports Jan, 2017 | Pubmed ID: 28071693
Amphotericin B, an Anti-Fungal Medication, Directly Increases the Cytotoxicity of NK Cells.
International journal of molecular sciences Jun, 2017 | Pubmed ID: 28608807
In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori Strains.
Gut and liver Jul, 2017 | Pubmed ID: 28750485
Fabrication of three-dimensional suspended, interlayered and hierarchical nanostructures by accuracy-improved electron beam lithography overlay.
Scientific reports Jul, 2017 | Pubmed ID: 28751643
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados